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Legionella pneumophila, a causative agent of bacterial pneumonia, survives inside phagocytic cells by avoiding
rapid targeting to the lysosome. This bacterium utilizes a type IVB secretion system, encoded by the dot/icm
genes, to replicate inside host cells. DotL, a critical component of the Dot/Icm secretion apparatus, functions
as the type IV coupling protein. In contrast to most dot/icm genes, which are dispensable for growth on
bacteriological media, dotL is required for the viability of wild-type L. pneumophila. Previously we reported that
dotL lethality could be suppressed by inactivation of the Dot/Icm complex via mutations in other dot/icm
genes. Here we report the isolation of non-dot/icm suppressors of this phenotype. These dotL suppressors
include insertions that disrupt the function of the L. pneumophila homologs of cpxR, djlA, lysS, and two novel
open reading frames, lpg0742 and lpg1594, that we have named ldsA and ldsB for lethality of dotL suppressor.
In addition to suppressing dotL lethality, inactivation of these genes in a wild-type strain background causes
a range of defects in L. pneumophila virulence traits, including intracellular growth, implicating these factors
in the proper function of the Dot/Icm complex. Consistent with previous data showing a role for the cpx system
in regulating expression of several dot/icm genes, the cpxR insertion mutant produced decreased levels of three
Dot/Icm proteins, DotA, IcmV, and IcmW. The remaining four suppressors did not affect the steady-state levels
of any Dot/Icm protein and are likely to represent the first identified factors necessary for assembly and/or
activation of the Dot/Icm secretion complex.
Legionella pneumophila is a gram-negative, facultative intra-
cellular parasite of freshwater protozoa. Although 48 species
of Legionella have been described, L. pneumophila is the most
common human pathogen in the genus Legionella and is the
primary causative agent of Legionnaires’ disease (15). Humans
can become infected with L. pneumophila when they are ex-
posed to aerosols from contaminated water sources (15). Upon
internalization by alveolar macrophages, L. pneumophila pre-
vents the acidification and lysosomal fusion of its phagosomal
compartment and co-opts secretory vesicles from the endoplas-
mic reticulum (18–20, 36). After these early steps, the phago-
some matures into a unique intracellular compartment, the
replicative phagosome, where the organism multiplies (17).
After the conclusion of a replicative cycle, L. pneumophila lyses
its host cell and infects surrounding phagocytic cells.
Numerous cell biological processes have been implicated in
the intracellular survival and replication of L. pneumophila,
including modulation of both apoptosis and autophagy (1, 2).
Although the role of these processes in L. pneumophila viru-
lence is not fully understood, it is clear that alteration of the
host cell endocytic pathway is critical to bacterial multiplica-
tion, as most avirulent L. pneumophila mutants are unable to
replicate inside host cells because they mistarget and fail to
form a replicative phagosome (5, 38). Complementation ex-
periments utilizing these mutants revealed that L. pneumophila
employs a specialized secretion system encoded by 26 “dot” or
“icm” genes to prevent nascent L. pneumophila-containing
phagosomes from entering into the endocytic pathway (39, 49).
The dot/icm genes encode an adapted conjugation apparatus
that has been classified as a type IVB secretion system (T4SS)
(10, 45). The L. pneumophila Dot/Icm T4SS is responsible for
injecting a dozen or more bacterial proteins into the cytoplasm
of host cells (4, 13, 14, 26, 30, 32). Although the specific
biological functions of most Dot/Icm substrates have yet to be
identified, many of these secreted proteins are expressed only
in the early stationary phase of growth (4, 26). This may explain
why the pathogen is not infectious during exponential growth
and must differentiate into a transmissive form prior to infect-
ing a new host cell (7).
Although critical to intracellular replication, most of the L.
pneumophila dot/icm genes are not required for in vitro growth
on bacteriological media (6, 40). However, it was recently
reported that three dot genes, dotL, dotM, and dotN, are es-
sential for the viability of L. pneumophila strain Lp02 (6). The
dotL gene is also essential for the viability of an unrelated L.
pneumophila strain, AA100, suggesting that this phenotype
may be a conserved trait (C. D. Vincent and J. P. Vogel,
unpublished data). Interestingly, it was discovered that the
dotL lethality phenotype could be suppressed by mutations in
the majority of the dot/icm genes (6). These observations led to
the model that loss of dotL is lethal to L. pneumophila due
to the accumulation of a toxic complex, perhaps an unregu-
lated secretion pore, in the envelope of the bacterium (6).
According to this model, suppression of dotL lethality could
be achieved either directly or indirectly. For example, mutation
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of a component of the T4SS would directly disrupt the toxic
secretion channel and would thus restore viability. Alterna-
tively, the mechanism of suppression could be indirect, for
example, by inactivation of genes needed for the proper as-
sembly and/or activity of the secretion channel.
To test this, we performed a screen for transposon mutants
that were able to survive in the absence of dotL (6). As pre-
dicted, the screen yielded a number of insertions in known
dot/icm genes, including four in dotA, two in dotG, one in dotI,
five in dotO, three in icmF, and one in icmX (6) and three in a
new dot gene, dotV (J. A. Sexton et al., unpublished data). We
report here the identification of non-dot/icm suppressor muta-
tions, including disruptions of the L. pneumophila homologs of
cpxR, lysS, djlA, and two novel genes, ldsA and ldsB. Although
inactivation of each of these genes suppresses dotL lethality,
their inactivation in the presence of wild-type DotL results in
varying effects on L. pneumophila virulence. These findings
indicate that multiple genes are likely to play key roles in
regulating the assembly and/or activation of the Dot/Icm se-
cretion complex.
MATERIALS AND METHODS
Bacterial strains and media. Strains used in this study are listed in Table 1. All
L. pneumophila strains used are derived from Lp02 (hsdR rpsL thyA), a wild-type
strain derived from the clinical isolate Philadelphia 1 (5). L. pneumophila strains
were grown on charcoal yeast extract agar (CYE) buffered with N-(2-acetamido)-
2-aminoethanesulfonic acid (ACES) or in ACES-buffered yeast extract broth
(AYE). Antibiotics (kanamycin, 30 g/ml; chloramphenicol, 5 g/ml; streptomy-
cin, 50 g/ml; and gentamicin, 7.5 g/ml), sucrose (5%), and thymidine (100
g/ml) were added as necessary. Escherichia coli strains were grown in Luria-
Bertani (LB) liquid medium or on LB agar plates. Antibiotics (ampicillin, 100
g/ml; chloramphenicol, 5 g/ml, and kanamycin, 20 g/ml) were added as
necessary.
Assay to determine suppression of dotL lethality. The assay used to screen
for dotL lethality suppression has been described previously (6). Plasmid
pJB1005 was transferred to L. pneumophila by using the RP4 conjugation system
encoded on plasmid pRK600 (22). L. pneumophila strains that had integrated the
plasmid onto the chromosome were selected by plating on medium containing
streptomycin and kanamycin. The resulting dotL/dotL::Cmr merodiploid strains
were plated on medium containing sucrose to select for resolution of the mero-
diploid to either dotL or dotL::Cmr. Sucrose-resistant colonies were streaked
on medium containing kanamycin to confirm that the integrated plasmid had
been lost and on medium containing chloramphenicol to screen for dotL or
dotL::Cmr.
Plasmid construction. All complementing clones were made in the RSF1010
cloning vector pJB908 (43). The cpxR cpxA clone (pJB3243) was generated by
amplifying the cpxR-cpxA operon, using primers JVP1147 and JVP1148. The
yitW lysS clone (pJB3197) was generated by amplifying the yitW-lysS operon,
using primers JVP1159 and JVP1218. The lysS clone (pJB3198) was generated by
amplifying lysS, using primers JVP1217 and JVP1218. The ldsA clone (pJB3411)
was generated by amplifying ldsA, using primers JVP1229 and JVP1230. The djlA
clone (pJB3230) was generated by amplifying djlA, using primers JVP1149 and
JVP1150. To generate a djlA-complementing clone in a plasmid that could be
transferred by the Dot/Icm complex, the djlA gene from pJB3230 was cloned into
pJB1627, generating plasmid pJB3192. All constructs were sequenced to confirm
that no errors were introduced during PCR amplification.
Growth of L. pneumophila strains in mouse bone marrow-derived macro-
phages. Mouse bone marrow-derived macrophages were isolated from the fe-
murs of female A/J mice as described previously (47). Intracellular growth of L.
pneumophila strains was assayed as described previously (4, 47).
Western analysis. Western blotting was performed using standard techniques
(4). Whole-cell extracts were generated from L. pneumophila cells grown to early
stationary phase in AYE. Western blotting was performed using antibodies
specific to DotL (diluted 1:10,000), DotB (diluted 1:500), DotG (diluted 1:1,000),
DotO (diluted 1:3,000), IcmR (diluted 1:3,000), IcmX (diluted 1:10,000), RalF
(diluted 1:3,000), SdeC (diluted 1:3,000), or isocitrate dehydrogenase (ICDH)
(diluted 1:10,000). Generation of DotL-, DotB-, and SdeC-specific antibodies
has been described previously (4, 6, 43). Antibodies to DotG, IcmX, IcmR, and
RalF were generated against purified amino-terminal His6 fusions injected into
rabbits (Cocalico, Inc.). Antibody specific to ICDH was kindly provided by L.
Sonenshein. Antibody specific to DotO was generously provided by R. Isberg. All
antibodies were detected using goat anti-rabbit secondary antibody conjugated to
horseradish peroxidase (Sigma) diluted 1:10,000 and an ECL detection kit (Am-
ersham Biosciences).
Conjugation assay. Conjugation assays were performed as described previ-
ously (42). L. pneumophila strains were grown to early stationary phase, and 1 
109 L. pneumophila donor cells were mixed with 1  1010 E. coli (strain ER1821)
recipient cells. Cell mixtures were incubated for 2 h at 37°C on 0.45 m-pore-size
filters (Millipore) placed on CYE plus thymidine agar plates. Cells were resus-
pended in sterile water and plated on LB plus ampicillin (100 g/ml) to deter-
mine the number of E. coli transconjugants. The conjugation frequency was
determined by dividing the number of E. coli plasmid recipients by the number
of L. pneumophila donors in each reaction. Shown are the averages and standard
deviations for triplicate conjugation reactions.
Cytotoxicity assay. Contact-dependent cytotoxicity assays were performed as
described previously (23, 46). L. pneumophila strains were added at the indicated
multiplicities of infection (MOI) to mouse bone marrow macrophages plated on
glass coverslips in 24-well tissue culture plates at a density of 1.5  105 bone
marrow macrophages per coverslip. Bacteria were pelleted onto the macro-
phages at 168  g for 5 min at room temperature and then incubated for 1 hour
at 37°C in 5% CO2. The coverslips were then inverted onto a drop of phosphate-
buffered saline (PBS) containing 25 g/ml ethidium bromide and 5 g/ml acri-
dine orange (23) and were immediately observed. To calculate cytotoxicity, the
number of ethidium bromide-positive macrophages was divided by the total
number of macrophages observed in each field of view. Shown are the averages
and standard deviations for four randomly selected fields of view scored for each
strain at each MOI.
Intracellular targeting assay. Targeting assays were performed essentially as
described previously (48). L. pneumophila cells grown to stationary phase were
added to the macrophages at an MOI of approximately 5, and infections were
allowed to proceed for 1 h at 37°C in 5% CO2. Infected macrophages were fixed
by the addition of paraformaldehyde-lysine-periodate containing 5% sucrose,
followed by incubation at room temperature for 20 min. Extracellular bacteria
were stained with polyclonal serum to L. pneumophila (3, 49) diluted 1:10,000 in
PBS containing 2% goat serum (PBSG), followed by goat anti-rabbit secondary
antibody conjugated to Cascade Blue (Molecular Probes) diluted 1:10,000 in
PBSG. Macrophages were then permeabilized with methanol, and intracellular
bacteria were decorated with polyclonal serum to L. pneumophila diluted
1:10,000 in PBSG and goat anti-rabbit secondary antibody conjugated to Alexa
Fluor 594 (Molecular Probes) diluted 1:10,000 in PBSG. LAMP-1 was labeled
with the antibody ID4B, which was developed by J. Thomas August and was
obtained from the Developmental Studies Hybridoma Bank, University of Iowa,
Department of Biological Sciences, Iowa City. It was diluted 1:2.5 in PBSG and
goat anti-rat secondary antibody conjugated to Alexa Fluor 488 (Molecular
Probes) diluted 1:100 in PBSG. Only intracellular bacteria were scored for
colocalization with the endocytic marker LAMP-1. The averages and standard
deviations of numbers obtained from three sets of 100 intracellular bacteria are
reported for each strain.
Immunofluorescence assay of SdeC secretion. Immunofluorescence staining of
secreted SdeC was performed as described previously (4). Cells were stained with
affinity-purified polyclonal serum raised to SdeC diluted 1:10, followed by incu-
bation with goat anti-rabbit antibody conjugated to Oregon green (Molecular
Probes) diluted 1:100. Bacterial and macrophage DNAs were stained with
4,6-diamidino-2-phenylindole (DAPI). For each strain, three counts of 100
bacteria were averaged. Results were normalized to wild-type secretion of
SdeC set at 100%.
RESULTS
dotL lethality can be suppressed by dot/icm and non-dot/
icm mutations. Although the dot/icm genes are required for
the intracellular growth of L. pneumophila, most of these genes
are dispensable for growth on bacteriological media (39, 40,
49). In contrast, dotL is essential for the viability of the L.
pneumophila strain Lp02 under all growth conditions (6). We
previously took advantage of dotL lethality to perform a
screen for mutations that allow growth in the absence of dotL
(6). The assay was based on resolution of a dotL/dotL::Cmr
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TABLE 1. Strains, plasmids and primers used
Strain, plasmid, or primer Relevant genotype or sequence Reference or source
E. coli strains
DH5pir DH5(pir) tet::Mu 24
ER1821 F glnV44 e14 (McrA) endA1 thi-1 (mcrC-mrr)114::IS10 New England Biolabs
(Beverly, MA)





Philadelphia 1 Wild-type strain 5, 27
Lp02 Philadelphia-1 rpsL hsdR thyA 5
Lp03 Lp02 dotA 5
JV1003 Lp02 dotL/dotL::Cmr 6
JV1005 Lp02 dotA dotL/dotL::Cmr 6
JV1139 Lp02  pJB908 4
JV1141 Lp03  pJB908 4
JV1372 Lp02 djlA dotL/dotL::Cmr
JV1484 Lp02 ldsB::Kanr This study
JV1485 Lp02 yitW::Kanr This study
JV1807 Lp02 cpxR::Kanr This study
JV1811 Lp02 djlA::Kanr This study
JV1817 Lp02 djlA::Kanr This study
JV1835 Lp02 ldsA::Kanr This study
JV1837 Lp02 ldsA::Kanr This study
JV4044 Lp02 lacking all 26 dot/icm genes This study
JV4070 JV1484  pJB908 This study
JV4073 JV1485  pJB908 This study
JV4075 JV1807  pJB908 This study
JV4077 JV1811  pJB908 This study
JV4078 JV1811  pJB3230 This study
JV4157 Lp02  pKB5 This study
JV4158 Lp03  pKB5 This study
JV4163 JV1484  pKB5 This study
JV4164 JV1485  pKB5 This study
JV4165 JV1807  pKB5 This study
JV4166 JV1811  pKB5 This study
JV4172 JV1835  pKB5 This study
JV4196 JV1807  pJB3243 This study
JV4313 JV1811  pJB3192 This study
JV4321 JV1485  pJB3197 This study
JV4322 JV1485  pJB3198 This study
JV4358 JV1835  pJB908 This study
JV4359 JV1835  pJB3411 This study
Plasmids
pJB908 pKB5 oriT 43
pJB1005 dotL::Cmr in pSR47S 6
pJB1627 pKB5  Cmr This study
pJB3192 pJB1627  djlA This study
pJB3197 pJB908  yitW lysS This study
pJB3198 pJB908  lysS This study
pJB3230 pJB908  djlA This study
pJB3243 pJB908  cpxR cpxA This study
pJB3411 pJB908  ldsA This study
pJK211-2 Mini-Tn10 transposon 6
pKB5 RSF1010 cloning vector 5
pRK600 RP4 helper plasmid 22
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merodiploid strain, as observed in Fig. 1. Total resolution
events can be detected by plating on CYE-sucrose plates, as
the merodiploid cassette contains a counterselectable marker
that confers sensitivity to sucrose. Specific resolution to the
dotL::Cmr locus can be identified by growth of the strain on
CYE plates containing sucrose and chloramphenicol. There-
fore, by comparing growth of the merodiploid on the two types
of media, it can be determined if a gene is essential or dis-
pensable. The essentiality of dotL can be observed by the
lowered plating efficiency of the wild-type dotL/dotL::Cmr
merodiploid on CYE-sucrose plates containing chloramphen-
icol (Fig. 1D). Of the total resolution events (Fig. 1A), fewer
than 1 in 1,000 resolved to the dotL::Cmr locus.
Although dotL is an essential gene, plating the dotL/dotL::
Cmr merodiploid strain on sucrose-chloramphenicol plates oc-
casionally did result in growth of a few colonies. These colonies
were confirmed to contain dotL deletions and were deduced to
be alive because they contained an additional mutation(s) ca-
pable of suppressing dotL lethality (6). Based on the fre-
quency at which these suppressors were observed, it seemed
likely that there must be a large number of genes whose inac-
tivation could alleviate the loss of dotL. This prediction proved
true, as inactivation of almost any dot/icm gene, including dotA,
is sufficient to suppress loss of dotL (Fig. 1B and E).
To identify additional suppressors, we previously reported a
screen for mini-Tn10 insertions that allowed L. pneumophila to
survive without the dotL gene (6). We identified 33 indepen-
dent strains containing insertions that suppressed the loss of
dotL. Nineteen of these strains possessed insertions in known
dot/icm genes (6) or in dotV (Sexton et al., unpublished data).
The remaining 14 suppressors contained insertions in open
reading frames (ORFs) that did not resemble known dot/icm
genes. These insertion mutations were able to suppress dotL
lethality at a frequency similar to that of a dotA mutation (Fig.
1C and 1F). In summary, dotL is an essential gene, but loss of
dotL can be suppressed by insertions in dot/icm genes and
non-dot/icm genes.
Identification of non-dot/icm suppressors of dotL lethality.
We report the sites of transposon insertion for 7 of the 15
non-dot/icm suppressors (Fig. 2 and Table 2). These seven
insertions are in five genes: the L. pneumophila homologs of
cpxR, djlA, and yitW, as well as two previously uncharacterized
L. pneumophila open reading frames, lpg0742 and lpg1594 (9).
Based on their ability to suppress loss of dotL, we have named
these genes ldsA and ldsB for lethality of dotL suppressor. We
obtained a single insertion in ldsB, cpxR, and yitW and two
independent insertions in ldsA and djlA (Fig. 2). However, it is
worth noting that the original screen described by Buscher
et al. was not performed to saturation (6).
Of the known genes, cpxR encodes the regulatory portion of
a two-component system that responds to the stress of mis-
folded proteins in the periplasm (34, 37). The djlA gene en-
codes a DnaJ homolog and is involved in sensing and repairing
misfolded proteins in the bacterial inner membrane (11). A
DjlA homolog has been shown to be required for the efficient
intracellular growth of Legionella dumoffii, although its specific
role was not determined (33). Finally, the yitW gene (lpg0606)
encodes a protein with similarity to metal-sulfur cluster bio-
FIG. 1. dotL is an essential gene, and mutations that suppress dotL lethality can be isolated. The essential nature of dotL can be demonstrated
by the failure of a dotL/dotL::Cmr merodiploid JV1003 to resolve to the dotL::Cmr locus when grown on CYE-sucrose plates containing
chloramphenicol (D). Resolution of the dotL/dotL::Cmr merodiploid to either the wild-type dotL or the dotL::Cmr locus can be detected by
colony formation on CYE-sucrose plates lacking chloramphenicol (A, B, and C). Growth on CYE-sucrose plates containing chloramphenicol (E
and F) is indicative of the presence of a mutation capable of suppressing the lethality caused by loss of dotL. Shown are the resolution abilities
of three dotL/dotL::Cmr merodiploid strains (the wild-type strain Lp02 JV1003, the dotA mutant JV1005, and a strain containing a novel
suppressor mutation, JV1372). In each case, resolution was assayed by plating 10-fold serial dilutions in a clockwise manner starting in the upper
left quadrant on CYE-sucrose plates (A, B, and C) or CYE-sucrose plates containing chloramphenicol (D, E, and F).
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synthetic enzymes in the DUF59 Pfam family. However, we
were able to determine that the suppression phenotype is not
due to disruption of yitW but is instead solely due to a polar
effect of the insertion on the expression of the downstream
gene, lysS (see below). lysS encodes lysyl tRNA synthetase,
which catalyzes the formation of Lys-tRNALys (31).
Of the novel suppressors, ldsA codes for a 417-amino-acid
protein that is predicted to be localized to the inner membrane via
eight transmembrane domains (9). Although homologs to LdsA
are conserved in other L. pneumophila strains, including Paris and
Lens (Lpp0807 and Lpl0778, respectively) (8), there do not ap-
pear to be highly homologous ldsA genes in any other bacterial
species, including the closely related pathogen Coxiella burnetii
(41). Four ORFs with very limited homology to ldsA can be
detected in GenBank, including SO0975, GSU1615, MCA2787,
and AdehDRAFT_0196 from Shewanella, Geobacter, Methylo-
coccus, and Anaeromyxobacter species, respectively. Each of
these ORFs is predicted to encode an inner membrane protein
with a size similar to that of LdsA, although none has been
assigned a function.
The ldsB gene is also predicted to encode a small inner
membrane protein with eight transmembrane domains. Similar
to the case for ldsA, the L. pneumophila strains Lens and Paris
contain highly conserved homologs to ldsB (lpl1431 and
lpp1552, respectively). Most gram-negative bacteria, including
C. burnetii, do not possess an LdsB homolog. The exception
may be Burkholderia pseudomallei, which is predicted to en-
code a protein with limited homology to LdsB (BLAST score
of 1e08 to LdsB). This B. pseudomallei hypothetical protein
has been annotated as encoding a membrane-associated phos-
pholipid phosphatase, although we could not detect this simi-
larity and LdsB does not appear to resemble a phosphatase. In
summary, LdsA and LdsB can be viewed as novel proteins that
likely do not have true homologs outside of the L. pneumophila
family.
Confirmation of suppressor phenotypes. To confirm that the
dotL lethality suppressor phenotype selected for in our
screen was specifically linked to the transposon insertions we
FIG. 2. Seven transposon insertions in non-dot/icm genes that suppress the lethality caused by loss of dotL were isolated. The insertions were
found in five genes, i.e., ldsB, cpxR, yitW, ldsA, and djlA. A map of the region surrounding the site of the insertion(s) is shown, with the gene
responsible for suppressing dotL lethality indicated with gray arrows, the genes surrounding the site of insertion indicated with white arrows, and the
sites of the transposon insertions shown with vertical black arrows. For each strain, the ability of the dotL/dotL::Cmr merodiploid to resolve to the
dotL::Cmr locus is indicated in the far right column, with the frequency of dotL mutant recovery normalized to the dotA strain JV1005 (100%).
TABLE 2. Description of the genes surrounding the dotL suppressors
lpg no.a Gene name Protein product/homology
lpg1591 rpsR 30S ribosomal protein S18
lpg1592 rpsF 30S ribosomal protein S6
lpg1593 csrA Carbon storage regulator
lpg1594 ldsB Lethality dotL suppressor B
lpg1595 NDb Hypothetical protein, ErfK homology
lpg1596 yfcX Enoyl coenzyme A hydratase
lpg1439 corC Mg2 and Co2 transporter
lpg1438 cpxA Cpx two-component sensor
lpg1437 cpxR Cpx two-component regulator
lpg1436 ND Hypothetical proteinc
lpg0604 nifS Aminotransferase
lpg0605 nifU Nitrogen fixation protein
lpg0606 yitW Metal-sulfur cluster biosynthetic enzyme
lpg0607 lysS Lysyl tRNA synthetase
lpg0608 ND S-Adenosylmethionine-dependent
methyltransferase
lpg0740 omp Rickettsia 17-kDa surface-exposed
antigen (lipoprotein)
lpg0741 ND Cystathionine-beta-synthase domain
lpg0742 ldsA Lethality dotL suppressor A
lpg0743 ND Glutamate synthetase
lpg0744 ND Sensory transduction (GGDEF domain)
lpg2340 kdtA 3-Deoxy-D-manno-octulosonic acid
transferase
lpg2341 djlA DnaJ-like protein
lpg2342 ND Hypothetical protein
lpg2343 sseJ like Lysophospholipase A
a Sites of insertion are indicated in boldface.
b ND, no gene name designated.
c Found only in Legionella species.
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identified, the transposon and surrounding DNA were trans-
formed into an unresolved dotL/dotL::Cmr merodiploid by
using natural competence (44). The resulting strains were then
assayed for their ability to suppress loss of dotL by resolving
the strains on selective media as described above. In each case,
resolution of merodiploids to the dotL::Cmr locus was com-
pared to that of a dotA mutant merodiploid. As shown in Fig.
2, each of the seven insertions was able to suppress dotL
lethality, with recovery rates ranging from 18% to 101% (nor-
malized to a dotA mutant set at 100%). Although the percent
recovery of dotL mutants varied, we observed that the inser-
tions with lower recovery rates of dotL mutants also exhibited
a corresponding diminished effect on Dot/Icm-related traits
(see below). Significantly, no resolution events to the dotL::
Cmr locus were recovered from the wild-type merodiploid (0/300
colonies scored). Thus, each newly created insertion mutant
appears able to suppress loss of dotL, demonstrating linkage of
this phenotype to the identified insertion.
The dotL suppressor mutants have varied effects on intra-
cellular replication. To determine the mechanism of dotL
lethality suppression, we assayed the effects of the insertion
mutations on the virulence properties of L. pneumophila. Since
the suppressor mutations were isolated in a strain that lacked
dotL, they were first transformed into a wild-type strain of L.
pneumophila by natural competence (44). These strains were
then grown in vitro to confirm that each resembled the wild-
type strain in growth rate, colony morphology, and motility
(data not shown). The mutants were then assayed for their
ability to replicate within macrophages derived from the bone
marrow of A/J mice (47). In these cells, the wild-type strain
Lp02 was able to multiply approximately 125-fold over the
course of the assay, whereas a dotA mutant was unable to
replicate (Fig. 3).
The seven insertion mutants exhibited a range of intracellu-
lar growth phenotypes, varying from wild-type growth to com-
plete attenuation of virulence (Fig. 3). For example, the ldsB
mutant (JV1484) grew robustly and was indistinguishable from
the wild-type strain Lp02 (Fig. 3). In contrast, the cpxR mutant
(JV1807) and the yitW mutant (JV1485) displayed partial de-
fects in intracellular growth, with each having grown approxi-
mately 10- to 20-fold less than the wild-type strain at day 3. A
strain containing an insertion in ldsA, JV1835, exhibited a
strong growth defect, resulting in no observable increase in
CFU over the course of the assay. Notably, this mutant did not
display a decrease in intracellular CFU, whereas the CFU of
the dotA mutant decreased approximately 10-fold by day 3.
The other ldsA mutant, JV1837, showed a similar intracellular
growth phenotype (data not shown). Finally, the djlA mutant
(JV1811) was the most attenuated in that it was unable to
replicate, lost viability, and had a phenotype resembling that of
a dotA mutant (Fig. 3). The other djlA mutant, JV1817, exhib-
ited the same level of attenuation (data not shown). Thus, the
FIG. 3. Intracellular growth of the suppressor mutants in bone marrow-derived macrophages from A/J mice. Each graph contains the same data
for a control strain that can grow in macrophages (JV1139, squares) and a dot mutant that is unable to grow inside macrophages (JV1141,
triangles). Also shown are growth data for each suppressor mutant containing the vector pJB908 (open circles) or the corresponding comple-
menting clone (filled circles). JV1484 is a ldsB mutant, JV1807 is a cpxR cpxA mutant, JV1485 is a yitW lysS mutant, JV1835 is an ldsA mutant,
and JV1811 is a djlA mutant. Complementation of the JV1484 mutant was not performed, since the strain grew similarly to a wild-type strain. Fold
growth was calculated as the number of CFU recovered each day divided by the number of CFU recovered immediately after infection (day 0).
Each time point represents the mean and standard deviation of CFU recovered from triplicate wells.




arch 26, 2014 by W






non-dot/icm dotL lethality suppressors vary significantly in
their intracellular replication defects, and we observed a pos-
itive correlation between the severity of their attenuation and
the level of recovery of dotL mutants.
The growth defects of the ldsA and djlA insertions could be
fully restored by introduction of the corresponding gene on a
plasmid (pJB3411 for ldsA or pJB3230 for djlA) (Fig. 3).
Since cpxR is in an operon with cpxA, and the genes each
encode an element of a two-component regulator whose com-
ponents function together, we assayed only complementation
of the cpxR insertion by introduction of a plasmid encoding the
cpxR-cpxA operon. The cpxR-cpxA operon plasmid pJB3243
was able to fully restore growth to the cpxR insertion strain
JV1807 (Fig. 3).
Likewise, yitW is found in an operon with a second gene,
lysS. Therefore, the growth defect of the yitW insertion could
be due to inactivation of yitW, of the downstream gene lysS, or
of both genes. Similar to the case for the cpxR insertion, ad-
dition of a plasmid (pJB3197) containing both genes to the
yitW insertion strain (JV1485) was able to fully restore growth
(data not shown), suggesting that both genes might be in-
volved. However, JV1485 could also be fully complemented by
introduction of just the lysS gene (pJB3198) (Fig. 3), leading to
the conclusion that the phenotype of the yitW transposon in-
sertion must be due to polar effects on expression of lysS.
Complementation of the ldsB mutant (JV1484) was not per-
formed, as this strain exhibited no intracellular growth defect.
As a result, we can conclude that ldsB is dispensable for intra-
cellular replication, the cpxR-cpxA operon and lysS are partially
required, and ldsA and djlA are necessary. The requirement for
djlA closely resembled that of most dot/icm genes.
The cpxR mutation, but not the other suppressor mutations,
affects expression of the Dot/Icm apparatus proteins. Based on
the observation that inactivation of various dot/icm genes is
able to suppress the lethality associated with loss of dotL (6),
we hypothesized that these non-dot/icm suppressors might af-
fect the expression and/or the stability of components of the
Dot/Icm type IV secretion machinery. For example, it is well
established for other bacterial species that cpxR/cpxA muta-
tions can affect the expression of many proteins (34, 37). To
determine if any of the dotL suppressor mutations affected
Dot/Icm protein levels, we performed Western blot analysis on
whole-cell lysates by using antibodies to 20 Dot/Icm proteins
and 2 secreted substrates. Six representative Dot/Icm proteins
and the two secreted substrates, RalF and SdeC, are shown in
Fig. 4A. An antibody that recognized the constitutively ex-
pressed housekeeping protein ICDH was included as a control.
None of the suppressor mutations significantly affected expres-
sion of the majority of the Dot/Icm apparatus proteins or of the
secreted substrates in either the wild-type or dotL strain
background in either the exponential or stationary phase of
growth (Fig. 4A and data not shown).
However, reduced amounts of two Dot/Icm proteins, IcmV
and IcmW, were observed in stationary-phase cultures of one
suppressor, the cpxR mutant (Fig. 4B). This effect was more
pronounced in exponentially growing cultures of the cpxR mu-
tant (Fig. 4C). Diminished levels of DotA, encoded down-
stream of icmV, were also observed in the cpxR mutant (data
not shown). Notably, IcmV levels appeared to be more affected
than DotA or IcmW levels. Based on our previous observation
that disruption of icmV or dotA, but not icmW, suppresses
dotL lethality (6), we hypothesized that decreased expression
of IcmV and DotA was the mechanism of dotL lethality
suppression of the cpxR mutant. To test this, we transformed a
plasmid containing the icmV dotA operon under a constitutive
promoter or the corresponding vector into the cpxR::Kanr
dotL mutant. Although transformants were obtained with the
vector, no transformants were recovered when the icmV dotA
plasmid was transformed into this strain (data not shown). This
result was dependent on inactivation of both dotL and cpxR, as
transformants could be obtained in the cpxR::Kanr mutant
background. Thus, the cpxR::Kanr mutant appears to suppress
dotL lethality through decreased levels of IcmV and DotA.
However, the virulence defects of the remaining suppressor
mutants do not appear to be due to altered expression or
stability of the Dot/Icm T4SS but may instead be due to the
improper assembly or activation of the secretion apparatus.
The dotL suppressor mutants have varied effects on plas-
mid mobilization. Having eliminated the most likely explana-
tion for the dotL suppressor phenotype, we employed a num-
FIG. 4. Only the cpxR suppressor mutation affects the steady-state
levels of the Dot/Icm secretion apparatus proteins. The following
strains were assayed: Lp02 (wild-type [WT] L. pneumophila) in lane 1,
JV4044 (a strain lacking all 26 dot/icm genes) in lane 2, JV1484 (an
ldsB mutant) in lane 3, JV1807 (a cpxR cpxA mutant) in lane 4, JV1485
(a yitW lysS mutant) in lane 5, JV1835 (an ldsA mutant) in lane 6, and
JV1811 (a djlA mutant) in lane 7. The seven strains were grown in
liquid AYE, and lysates were analyzed by Western blotting using
antibodies specific to the proteins listed to the right of each blot.
(A) Representative proteins not affected by the suppressor mutations,
using lysates generated from stationary-phase cultures (optical density
at 600 nm of approximately 3.1). Shown are Western blots using an-
tibodies recognizing six representative components of the Dot/Icm
complex (DotL, DotB, DotG, DotO, IcmR, and IcmX), two secreted
substrates (RalF and SdeC), and the constitutively expressed house-
keeping protein ICDH. (B) Dot/Icm proteins affected by the
cpxR::Kanr mutation, assaying lysates generated from early-stationary-
phase cultures (optical density at 600 nm of approximately 3.1).
(C) Dot/Icm proteins affected by the cpxR::Kanr mutation, assaying
lysates generated from exponential-phase cultures (optical density at
600 nm of approximately 1.5). In both panels B and C, antibodies
recognizing IcmV, IcmW, and ICDH were used.
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ber of Dot/Icm-dependent assays to test the dotL suppressor
mutants for Dot/Icm T4SS functionality. The first assay we
used is based on the ability of the L. pneumophila Dot/Icm
T4SS to transfer a plasmid from one bacterium to another
(39, 49). A wild-type L. pneumophila strain, JV4157, mobi-
lized pKB5 with an efficiency of 8.1  106 transconjugants
per donor, whereas a dotA mutant (JV4158) was completely
deficient for plasmid transfer (limit of detection  1 
109) (Fig. 5A).
The ldsB (JV4163), cpxR cpxA (JV4165), and lysS (JV4164)
mutants were each able to conjugate pKB5 by the Dot/Icm
system but with slightly lower efficiency than wild-type cells
(2.0  106, 1.2  106, and 1.7  106 transconjugants per
donor, respectively). Consistent with its more severe intracel-
lular growth defect, the ldsA mutant (JV4172) was 48-fold less
efficient than the wild type at plasmid transfer (1.7  107
transconjugants per donor). The djlA mutant (JV4166), which
was severely attenuated for intracellular growth, was almost
completely defective for plasmid transfer (6.7  109
transconjugants per donor). Although we had shown comple-
mentation of the intracellular growth defect of our djlA mutant
(Fig. 3), we tested whether the conjugation defect of the djlA
mutant could also be complemented. As expected, the plasmid
mobilization defect of the djlA mutant could be restored to
wild-type levels when a djlA-expressing plasmid, pJB3192, was
present, confirming that the phenotype of the djlA mutant is
specifically due to the transposon insertion (Fig. 5B). In sum-
mary, three of the suppressors exhibited only subtle defects in
plasmid transfer, the ldsA mutant exhibited an intermediate
defect, and the djlA mutant was severely defective.
The dotL suppressor mutants have varied effects on con-
tact-dependent cytotoxicity. As an additional measure of Dot/
Icm T4SS functionality, we assayed the ability of the dotL
suppressor mutants to cause rapid cytotoxicity of host macro-
phages. This form of cytotoxicity, also termed “contact-depen-
dent cytotoxicity,” is observed at high MOI and results in host
cell death consistent with the insertion of pores in the host cell
membrane (23). Rapid contact-dependent cytotoxicity requires
the majority of the Dot/Icm proteins, excluding the type IV
adaptors IcmS and IcmW, and therefore accurately reflects the
presence of an assembled and functional T4SS (12, 23).
To assay cytotoxicity, L. pneumophila strains were pelleted
onto mouse bone marrow-derived macrophages at a range of
MOI. After incubation for 1 hour, the infected macrophages
were stained with acridine orange and ethidium bromide in
order to determine their intactness. Live, intact cells stain
green, whereas permeabilized cells stain red due to the uptake
of ethidium bromide (23). Representative images of the cyto-
toxic effects of a wild-type strain, a dotA mutant, and the dotL
suppressor mutant strains are shown in Fig. 6A to H. Unin-
fected cells are green, as they are impermeable to ethidium
bromide (Fig. 6A). Infection using a wild-type strain at an MOI
of 50 bacteria/macrophage resulted in the majority of the mac-
rophages being permeabilized (Fig. 6B). Infection using a dotA
mutant at an identical MOI caused no cytotoxicity (Fig. 6C).
Macrophages infected with the ldsB mutant (Fig. 6D), the cpxR
cpxA mutant (Fig. 6E), and the lysS mutant (Fig. 6F) closely
resembled those infected with wild-type cells (Fig. 6B). In
contrast, the ldsA mutant (Fig. 6G) and the djlA mutant (Fig.
6H) were significantly less cytotoxic but did not appear to be
as defective as the dotA mutant (compare Fig. 6G and H with
Fig. 6C).
To examine this phenotype in more detail, the infections
were repeated using a range of MOI and cytotoxicity was
quantitated (Fig. 6I). As before, the ldsB mutant (JV1484), the
cpxR cpxA mutant (JV1807), and the lysS mutant (JV1485)
closely resembled the wild-type strain (Lp02) at each MOI.
The ldsA mutant appeared equally cytotoxic as the wild-type
strain when assayed using the highest MOI (500), where both
permeabilized nearly 100% of the macrophages. However, it
was clearly attenuated when examined using an intermediate
MOI (Fig. 6I). Quantitation of the djlA mutant cytotoxicity
FIG. 5. Ability of dotL suppressors to mobilize a plasmid. Strains were assayed for the ability to mobilize an RSF1010 plasmid from one
bacterium to another via the Dot/Icm secretion system. Strains containing the RSF1010 plasmid pKB5 were mated with E. coli strain ER1821, and
transconjugants were selected on LB plates containing ampicillin. (A) Strains used were JV4157 (Lp02 plus pKB5), JV4158 (Lp03 plus pKB5),
JV4163 (ldsB plus pKB5), JV4165 (cpxR cpxA plus pKB5), JV4164 (yitW lysS plus pKB5), JV4172 (ldsA plus pKB5), and JV4166 (djlA plus pKB5).
(B) The conjugation defect of the djlA mutant can be complemented by the presence of the wild-type djlA gene. Strains JV4157 (wild type [WT]
plus pKB5), JV4158 (dotA plus pKB5), JV4166 (djlA plus pKB5), and JV4313 (djlA plus djlA-complementing clone) were assayed for the ability
to mobilize RSF1010 as described above. Data shown are the average number of transconjugants per L. pneumophila donor  the standard
deviation obtained from three reactions. v, vector.
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revealed that although it was severely attenuated at lower
MOI, it retained some activity (14% cytotoxicity) when assayed
using the highest MOI. This is strikingly in contrast to the dotA
mutant, which was not cytotoxic at any MOI tested (Fig. 6I). As
before, the defect in cytotoxicity of the djlA mutant could be
complemented when djlA was supplied in trans on a plasmid
(Fig. 6J). These results demonstrate that the Dot/Icm secretion
complex functions normally in the ldsB, lysS, and cpxR cpxA
mutants. However, the T4SS is not fully functional in the ldsA
and djlA mutants, although both do retain some residual
activity.
The ldsA and djlA mutants are defective in altering the
endocytic pathway of host cells. Since the ldsA and djlA mu-
tants were the only suppressors that exhibited severe defects in
dot/icm-related phenotypes, we examined the intracellular
growth defect of these mutants further. It is possible that these
mutants are impaired for growth within macrophages simply
because they replicate at lower rates inside host cells. Alter-
FIG. 6. Contact-dependent cytotoxicity of the dotL suppressors. Cytotoxic effects of L. pneumophila strains on mouse bone marrow-derived
macrophages were examined using vital stains. Bacteria were incubated with mouse bone marrow-derived macrophages for 1 h. Cytotoxicity was
assayed by staining with ethidium bromide and acridine orange. Live cells appear green, whereas permeabilized cells appear green with red nuclei.
Representative images for infections done using an MOI of 50 are shown for the following strains: (A) uninfected macrophages, (B) Lp02 (wild
type), (C) Lp03 (dotA), (D) JV1484 (ldsB), (E) JV1807 (cpxR cpxA), (F) JV1485 (yitW lysS)” (G) JV1835 (ldsA), and (H) JV1811 (djlA).
(I) Quantitation of cytotoxicity, using four different MOI (0, 5, 50, or 500). Results are indicated as the percentage of ethidium bromide
(EtBr)-positive-staining macrophages divided by the total number of macrophages observed per field. The averages and standard deviations for
four randomly selected fields are shown for each strain at each MOI indicated. (J) Complementation of the cytotoxicity defect of the djlA mutant.
Strains JV1139 (wild type [WT] plus pJB908), JV1141 (dotA plus pJB908), JV4077 (djlA plus pJB908), and JV4078 (djlA plus djlA-complementing
clone) were assayed for contact-dependent cytotoxicity as described for panel I. v, vector.
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natively, they could lack a function that is necessary for intra-
cellular replication. For example, they could be unable to alter
intracellular trafficking of the host cell, a process that abso-
lutely requires a functional Dot/Icm type IV secretion system.
To assess L. pneumophila avoidance of the endocytic pathway,
we quantitated colocalization of Legionella-containing phago-
somes with the endocytic marker LAMP-1 (48). As shown in
Fig. 7, the majority of wild-type L. pneumophila bacteria did
not colocalize with LAMP-1, whereas only 10% of dotA mu-
tants were LAMP-1 negative. Both the ldsA mutant and the
djlA mutant resembled the dotA mutant in that they were
severely defective in altering the endocytic pathway. The ldsA
mutant was slightly less attenuated than the dotA mutant for
avoiding the endocytic marker LAMP-1 (17% LAMP-1 nega-
tive), while the djlA mutant was indistinguishable from the
dotA mutant (8% LAMP-1 negative). As observed with intra-
cellular growth, the targeting defect of each of the mutants was
fully restored by introduction of complementing clones (86%
and 73% LAMP-1 avoidance, respectively). Because the sever-
ity of the intracellular growth defect correlated with the defect
in targeting for both mutants, it seems likely that the observed
defects in intracellular growth are caused solely by the inability
to alter the host endocytic pathway.
The ldsA and djlA mutants are defective in the secretion of
the Dot/Icm substrate SdeC. Alteration of the host endocytic
pathway by the Dot/Icm T4SS is mediated by the export of
protein substrates into the cytoplasm of the host cell (4, 13, 14,
26, 30, 32). Export of a representative substrate, SdeC, can be
visualized by immunofluorescence staining of infected macro-
phages with an antibody raised against SdeC (4). Similarly to
other L. pneumophila T4SS substrates, SdeC is secreted into
the host cytoplasm, adjacent to the poles of the bacterium,
where it remains associated with the phagosome (4).
To assay SdeC export by the ldsA and djlA mutants, the
strains were added to mouse bone marrow-derived macro-
phages, and infections were allowed to proceed for 30 min
prior to fixation and staining. DAPI (blue) was used to stain
macrophage and bacterial DNAs, whereas the SdeC antibody
was decorated with a goat anti-rabbit antibody conjugated to
Oregon green. Representative images of each strain are shown
FIG. 7. The ldsA mutant and the djlA mutant are defective in al-
tering the host cell endocytic pathway. Colocalization of the endocytic
marker LAMP-1 with intracellular bacteria was assayed by immuno-
fluorescence microscopy. Strains JV1139 (wild type [WT] plus
pJB908), JV1141 (dotA plus pJB908), JV4358 (ldsA plus pJB908),
JV4359 (ldsA plus ldsA-complementing clone), JV4077 (djlA plus
pJB908), and JV4078 (djlA plus djlA-complementing clone) were used
to infect mouse bone marrow-derived macrophages for 1 hour prior to
fixation and staining for intracellular versus extracellular bacteria and
for LAMP-1. Avoidance of LAMP-1 by intracellular L. pneumophila is
shown as the average and standard deviation of three counts of 100
bacteria. v, vector.
FIG. 8. The djlA mutant is defective in export of substrates of the Dot/Icm secretion system. Dot/Icm-mediated secretion of SdeC was assayed
by immunofluorescence microscopy. Mouse bone marrow-derived macrophages were infected with various L. pneumophila strains for 30 minutes
prior to fixation and staining with DAPI (to detect DNA) and a polyclonal serum that detects SdeC. (A) Representative immunofluorescence
images of macrophages infected with strains JV1139 (wild type [WT] plus pJB908), JV1141 (dotA plus pJB908), JV4077 (djlA plus pJB908), and
JV4078 (djlA plus djlA-complementing clone). DAPI staining for DNA is shown in the left panels, SdeC staining is shown in the center panels,
and merged images are shown in the right panels. (B) The results in panel A were quantitated by scoring intracellular L. pneumophila cells for the
presence of SdeC on the surface of the phagosome. The results were normalized to the amount of SdeC secretion observed with wild-type L.
pneumophila set at 100%. Shown are the averages and standard deviations of three counts of 100 intracellular bacteria. v, vector.
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in Fig. 8A, with quantitation provided in Fig. 8B. As described
previously (4), wild-type cells (JV1139) frequently exhibit foci
of SdeC staining at one or both poles of the phagosome,
whereas dotA mutants (JV1141) do not. Consistent with the
defect in altering the endocytic pathway as observed by
LAMP-1 colocalization, the djlA mutant (JV4077) was almost
completely defective for SdeC secretion (Fig. 8A and B). The
ldsA mutant was also defective for SdeC export, although not
to the same extent (data not shown). Secretion of SdeC was
fully restored in each mutant by the introduction of the corre-
sponding complementing clone (Fig. 8 and data not shown).
Thus, the intracellular growth defect of the dotL suppressor
mutants ldsA and djlA appears to be due to a failure to prop-
erly export T4SS substrates and therefore a failure to alter the
endocytic pathway of the host cell.
DISCUSSION
We report here the characterization of five genes that were
isolated in a screen for mini-Tn10 insertions able to suppress
the lethality caused by loss of dotL. The insertions were in
cpxR, djlA, yitW, and two novel genes, which we have named
ldsA and ldsB (lethality of dotL suppressor). Each of these
suppressor mutations conferred the ability of L. pneumophila
to survive in the absence of dotL. When assayed in a dotL
background, these mutants exhibited differential effects on
Dot/Icm-dependent assays. These results support the hypoth-
esis that there are multiple means to suppress dotL lethality,
including by decreasing expression of dot/icm genes and by
diminishing the assembly and/or activity of the L. pneumophila
Dot/Icm secretion system.
The CpxRA (conjugative plasmid expression) stress re-
sponse system is a two-component regulatory system induced
in response to extracytoplasmic signals generated in the cell
envelope, principally misfolded proteins in the periplasm (34,
37). Once these signals are detected, the system is responsible
for activating the expression of a number of factors required
for responding to cell envelope stress (35). In addition to a role
in F plasmid conjugation (28), the Cpx system has been impli-
cated in several virulence mechanisms, including invasion (Sal-
monella enterica), transcriptional regulation (Shigella sonnei),
P-pilus biogenesis (uropathogenic E. coli), and assembly of
type IV bundle-forming pili (enteropathogenic E. coli) (re-
viewed in reference 34).
Based on our model of dotL toxicity and the important role
of the Cpx system in responding to periplasmic stress in other
organisms, it is not surprising that this system is involved in the
response to loss of dotL. We hypothesized that the cpx muta-
tion could affect expression of dot/icm genes, thereby suppress-
ing dotL lethality due to lowered levels of Dot/Icm proteins.
This hypothesis was supported by a previous study, using -
galactosidase reporters, that showed decreased transcription of
icmR, icmV, and icmW in a cpxR mutant (16). Although we did
not observe that IcmR protein levels were significantly affected
by a cpxR insertion (Fig. 4A), we did observe an effect on
DotA, IcmV, and IcmW. Interestingly, the cpxR::Kanr mutant
had only a minor effect on the levels of IcmX (Fig. 4A), a
protein encoded downstream of icmW. By assaying the effects
of overexpression of IcmV and DotA, we were able to dem-
onstrate that decreased levels of IcmV and DotA were solely
responsible for suppression of dotL lethality in the
cpxR::Kanr mutant. This is consistent with our previous obser-
vation that disruption of icmV or dotA, but not icmW, sup-
presses dotL lethality (6). Surprisingly, although decreased
IcmV and DotA levels were sufficient to suppress loss of dotL
in the cpxR::Kanr mutant, it was still able to conjugate and
remained cytotoxic. Thus, the dotL lethality phenotype is
more sensitive to decreased levels of Dot/Icm proteins than
other Dot/Icm-associated traits.
The remaining non-dot/icm suppressors described here
likely represent mutations that indirectly affect the activity of
the L. pneumophila T4SS or mutations that do not affect the
Dot/Icm complex itself but allow the strain to survive in the
absence of dotL. These mutations can be subdivided into three
phenotypic classes: (i) mutations that affect virulence by dis-
rupting the assembly and/or the activation of the Dot/Icm
system (e.g., ldsA and djlA), (ii) mutations that negatively affect
the ability of the strain to grow in macrophages but do not
appear to grossly affect the assembly and function of the Dot/
Icm complex (e.g., lysS), and (iii) mutations that do not affect
any of the virulence-related assays (e.g., ldsB). Before exam-
ining the overall implications of these suppressors, we will
discuss each class separately.
The first class of mutants reported here includes the ldsA
and djlA mutants. Each of these mutants was much more
attenuated in intracellular growth than the other suppressor
mutants, and the djlA mutant was completely defective for
growth in macrophages. Further analysis revealed that the
reason for the attenuation of these mutants is that they likely
affect the assembly and/or activity of the Dot/Icm apparatus.
Although these mutants still make wild-type levels of Dot/Icm
proteins and substrates, they are less efficient than the wild
type at avoiding phagosome-lysosome fusion and exhibit de-
creased Dot/Icm-mediated plasmid transfer and contact-de-
pendent cytotoxicity. Finally, both mutants are severely atten-
uated for the secretion of a T4SS substrate, SdeC, into the
cytoplasm of macrophages. Thus, as predicted, our dotL le-
thality suppressor screen did identify factors involved in the
assembly or activity of the Dot/Icm apparatus.
The ldsA gene encodes a polytopic inner membrane protein
that does not contain any distinguishing motifs, making pre-
diction of its molecular function difficult. Based on the pro-
tein’s putative membrane localization and the Dot/Icm-related
defects associated with loss of LdsA, it is formally possible that
LdsA is an additional Dot/Icm protein. However, we do not
favor this possibility since LdsA lacks homology to a compo-
nent of any known type IV secretion system and is encoded
distantly from the two Dot/Icm pathogenicity islands (49).
In contrast to the ldsA mutant, it is easier to propose an
explanation for the djlA mutant. DjlA (for DnaJ-like protein) is
an inner membrane-anchored homolog of DnaJ with its J do-
main located in the cytoplasm (11). Similarly to DnaJ, E. coli
DjlA is known to interact with the DnaK (Hsp70) chaperone
and stimulate its ATPase activity (50). DjlA has been proposed
to function as a chaperone for the assembly and/or activity of
membrane proteins and may play a role as a sensor of envelope
stress (21). The involvement of a stress response system in the
suppression of dotL lethality is consistent with our model that
the absence of DotL leads to the accumulation of a toxic
subcomplex in the envelope of cells. Based on the proposed
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activities of E. coli DjlA, the highly conserved L. pneumophila
homolog is likely to be involved in sensing misfolded proteins
in the membrane and assisting in their proper folding. There-
fore, L. pneumophila may require DjlA to properly fold and
assemble components of the Dot/Icm complex. Loss of djlA
would therefore phenocopy dot/icm mutations and suppress
dotL lethality by a similar mechanism. Additionally, djlA has
also been implicated as being required for the intracellular
growth of another Legionella species, Legionella dumoffii (33).
Because our djlA mutant still appears to synthesize compo-
nents of the Dot/Icm apparatus and yet is severely defective for
all Dot/Icm-dependent traits, it likely serves as a key factor in
the assembly/quality control of the L. pneumophila T4SS. To
our knowledge, DjlA is the first such factor identified.
The second class of mutations reported here includes an
insertion in yitW that affects the expression of the lysyl-tRNA
synthetase gene lysS. This mutation caused subtle defects in
intracellular growth in mouse bone marrow-derived macro-
phages. However, the mutant did not display a significant de-
fect in plasmid transfer or contact-dependent cytotoxicity,
traits requiring a functional Dot/Icm secretion apparatus. LysS
is an aminoacyl-tRNA synthetase that catalyzes the formation
of Lys-tRNALys, which is then used to insert lysine into pro-
teins (31). It was surprising to obtain an insertion that ap-
peared to down-regulate the expression of lysS, since most
tRNA synthetases are essential. However, it is possible that the
yitW::Kanr allele exhibited only an incomplete polar effect on
lysS, thereby partially down-regulating its expression. Alterna-
tively, lysS may not be essential because Legionella possesses a
homolog of lysU, which encodes a secondary, inducible form of
lysyl-tRNA synthetase in other bacterial species (31). Although
the molecular mechanism of suppression by inactivation of lysS
remains cryptic, the Lys-tRNALys molecule has been impli-
cated in additional roles, including functioning as a signaling
molecule (31). It is thus possible that the mechanism of lysS
suppression of dotL lethality is indirect and may be unlinked
to its role in protein synthesis.
The insertion in ldsB was the only mutant in the third class
identified in this screen whose inactivation suppressed dotL
lethality but did not affect the virulence of a dotL strain of L.
pneumophila. LdsB is predicted to be a novel polytopic, inner
membrane protein that does not possess any apparent protein
motifs, thus precluding an obvious prediction of function. Al-
though we do not understand the molecular mechanism of ldsB
suppression of dotL lethality, the ability of this mutant to
replicate normally in macrophages suggests that the suppres-
sion may be mediated by an indirect mechanism of action (see
below). Nevertheless, the identification of ldsB is important for
two reasons. First, since a dotL strain is not viable in the Lp02
background, it was previously only possible to examine this
strain lacking dotL in the presence of another dot/icm muta-
tion, e.g., dotL dotA, thus severely complicating the analysis
of the dotL phenotype. As a result of this discovery, it is now
possible to examine the dot/icm phenotypes of Lp02 lacking
dotL in the dotL ldsB strain. Second, the existence of a
dotL lethality suppressor that does not affect the intracellular
replication of L. pneumophila provides credence to our pro-
posal that the JR32 dotL strain is viable because the JR32
strain background contains a suppressor mutation (6).
Based on our initial observation that dot/icm mutations
could suppress loss of dotL, we proposed that an L. pneumo-
phila dotL strain is not viable because it accumulates a toxic
substrate in the cell envelope. This poisonous structure could
be a misfolded Dot/Icm subcomplex, similar to pilin subunits
that accumulate in the absence of the P-pilus chaperone PilD
(25). Alternatively, the toxic substrate might be a normally
assembled Dot/Icm subcomplex that functions improperly in
the absence of DotL, perhaps as an unregulated secretion pore
that leads to a loss of homeostasis. The former model implies
that accumulation of a subcomplex, likely to consist of a few
Dot/Icm proteins, is responsible for the toxicity. If this were the
case, inactivation of only a few dot/icm genes should suppress
dotL lethality. Instead, inactivation of almost any dot/icm
gene suppresses loss of dotL, which is more consistent with
the toxicity being due to an improperly functioning Dot/Icm
complex.
Taken in this context, inactivation of factors that are re-
quired for the proper assembly or activity of the Dot/Icm
complex, such as DjlA, should also suppress dotL lethality.
However, the existence of suppressors that replicate in mac-
rophages and have only subtle or no effects on the Dot/Icm
complex in a dotL background is perplexing. We propose two
possible explanations for this conundrum. First, the number of
functional Dot/Icm complexes required for intracellular
growth may be significantly less than the number of toxic
dotL complexes required for cell death. In this case, a muta-
tion that decreases the number of functional complexes may be
able to suppress dotL lethality but have no effect on intracel-
lular growth in a wild-type background. Alternatively, one
could imagine a type of mutation that induces a response
capable of allowing a dotL strain to live that is not needed for
the normal assembly/activity of the complex. For example,
inactivation of a repressor of a periplasmic protease might
allow the elimination of a toxic Dot/Icm subcomplex but yet
not be required in a wild-type cell. In either case, further
examination of the dotL lethality suppressors should reveal
insights into both the normal assembly/activity of the T4SS and
envelope stress response systems in L. pneumophila.
ACKNOWLEDGMENTS
We thank James Kirby for the generous gift of pJK211-2 and Petra
Levin and Jessica Sexton for critical reading of the manuscript.
This work was funded by NIH grant AI48052 to J.P.V.
REFERENCES
1. Abu-Zant, A., M. Santic, M. Molmeret, S. Jones, J. Helbig, and Y. Abu
Kwaik. 2005. Incomplete activation of macrophage apoptosis during intra-
cellular replication of Legionella pneumophila. Infect. Immun. 73:5339–5349.
2. Amer, A. O., and M. S. Swanson. 2005. Autophagy is an immediate macro-
phage response to Legionella pneumophila. Cell. Microbiol. 7:765–778.
3. Andrews, H. L., J. P. Vogel, and R. R. Isberg. 1998. Identification of linked
Legionella pneumophila genes essential for intracellular growth and evasion
of the endocytic pathway. Infect. Immun. 66:950–958.
4. Bardill, J. P., J. L. Miller, and J. P. Vogel. 2005. IcmS-dependent translo-
cation of SdeA into macrophages by the Legionella pneumophila type IV
secretion system. Mol. Microbiol. 56:90–103.
5. Berger, K. H., and R. R. Isberg. 1993. Two distinct defects in intracellular
growth complemented by a single genetic locus in Legionella pneumophila.
Mol. Microbiol. 7:7–19.
6. Buscher, B. A., G. M. Conover, J. L. Miller, S. A. Vogel, S. N. Meyers, R. R.
Isberg, and J. P. Vogel. 2005. The DotL protein, a member of the TraG-
coupling protein family, is essential for viability of Legionella pneumophila
strain Lp02. J. Bacteriol. 187:2927–2938.
7. Byrne, B., and M. S. Swanson. 1998. Expression of Legionella pneumophila
virulence traits in response to growth conditions. Infect. Immun. 66:3029–
3034.




arch 26, 2014 by W






8. Cazalet, C., C. Rusniok, H. Bruggemann, N. Zidane, A. Magnier, L. Ma, M.
Tichit, S. Jarraud, C. Bouchier, F. Vandenesch, F. Kunst, J. Etienne, P.
Glaser, and C. Buchrieser. 2004. Evidence in the Legionella pneumophila
genome for exploitation of host cell functions and high genome plasticity.
Nat. Genet. 36:1165–1173.
9. Chien, M., I. Morozova, S. Shi, H. Sheng, J. Chen, S. M. Gomez, G. Asamani,
K. Hill, J. Nuara, M. Feder, J. Rineer, J. J. Greenberg, V. Steshenko, S. H.
Park, B. Zhao, E. Teplitskaya, J. R. Edwards, S. Pampou, A. Georghiou, I. C.
Chou, W. Iannuccilli, M. E. Ulz, D. H. Kim, A. Geringer-Sameth, C.
Goldsberry, P. Morozov, S. G. Fischer, G. Segal, X. Qu, A. Rzhetsky, P.
Zhang, E. Cayanis, P. J. De Jong, J. Ju, S. Kalachikov, H. A. Shuman, and
J. J. Russo. 2004. The genomic sequence of the accidental pathogen Legio-
nella pneumophila. Science 305:1966–1968.
10. Christie, P. J., and J. P. Vogel. 2000. Bacterial type IV secretion: conjugation
systems adapted to deliver effector molecules to host cells. Trends Microbiol.
8:354–360.
11. Clarke, D. J., A. Jacq, and I. B. Holland. 1996. A novel DnaJ-like protein in
Escherichia coli inserts into the cytoplasmic membrane with a type III topol-
ogy. Mol. Microbiol. 20:1273–1286.
12. Coers, J., J. C. Kagan, M. Matthews, H. Nagai, D. M. Zuckman, and C. R.
Roy. 2000. Identification of Icm protein complexes that play distinct roles in
the biogenesis of an organelle permissive for Legionella pneumophila intra-
cellular growth. Mol. Microbiol. 38:719–736.
13. Conover, G. M., I. Derre, J. P. Vogel, and R. R. Isberg. 2003. The Legionella
pneumophila LidA protein: a translocated substrate of the Dot/Icm system
associated with maintenance of bacterial integrity. Mol. Microbiol. 48:305–
321.
14. de Felipe, K. S., S. Pampou, O. S. Jovanovic, C. D. Pericone, S. F. Ye, S.
Kalachikov, and H. A. Shuman. 2005. Evidence for acquisition of Legionella
type IV secretion substrates via interdomain horizontal gene transfer. J.
Bacteriol. 187:7716–7726.
15. Fields, B. S., R. F. Benson, and R. E. Besser. 2002. Legionella and Legion-
naires’ disease: 25 years of investigation. Clin. Microbiol. Rev. 15:506–526.
16. Gal-Mor, O., and G. Segal. 2003. Identification of CpxR as a positive regu-
lator of icm and dot virulence genes of Legionella pneumophila. J. Bacteriol.
185:4908–4919.
17. Horwitz, M. A. 1983. Formation of a novel phagosome by the Legionnaires’
disease bacterium (Legionella pneumophila) in human monocytes. J. Exp.
Med. 158:1319–1331.
18. Horwitz, M. A. 1983. The Legionnaires’ disease bacterium (Legionella pneu-
mophila) inhibits phagosome-lysosome fusion in human monocytes. J. Exp.
Med. 158:2108–2126.
19. Horwitz, M. A., and F. R. Maxfield. 1984. Legionella pneumophila inhibits
acidification of its phagosome in human monocytes. J. Cell Biol. 99:1936–
1943.
20. Kagan, J. C., and C. R. Roy. 2002. Legionella phagosomes intercept vesicular
traffic from endoplasmic reticulum exit sites. Nat. Cell Biol. 4:945–954.
21. Kelley, W. L., and C. Georgopoulos. 1997. Positive control of the two-
component RcsC/B signal transduction network by DjlA: a member of the
DnaJ family of molecular chaperones in Escherichia coli. Mol. Microbiol.
25:913–931.
22. Kessler, B., V. de Lorenzo, and K. N. Timmis. 1992. A general system to
integrate lacZ fusions into the chromosomes of gram-negative eubacteria:
regulation of the Pm promoter of the TOL plasmid studied with all control-
ling elements in monocopy. Mol. Gen. Genet. 233:293–301.
23. Kirby, J. E., J. P. Vogel, H. L. Andrews, and R. R. Isberg. 1998. Evidence for
pore-forming ability by Legionella pneumophila. Mol. Microbiol. 27:323–336.
24. Kolter, R., M. Inuzuka, and D. R. Helinski. 1978. Trans-complementation-
dependent replication of a low molecular weight origin fragment from plas-
mid R6K. Cell 15:1199–1208.
25. Lee, Y. M., P. A. DiGiuseppe, T. J. Silhavy, and S. J. Hultgren. 2004. P pilus
assembly motif necessary for activation of the CpxRA pathway by PapE in
Escherichia coli. J. Bacteriol. 186:4326–4337.
26. Luo, Z. Q., and R. R. Isberg. 2004. Multiple substrates of the Legionella
pneumophila Dot/Icm system identified by interbacterial protein transfer.
Proc. Natl. Acad. Sci. USA 101:841–846.
27. Marra, A., and H. A. Shuman. 1989. Isolation of a Legionella pneumophila
restriction mutant with increased ability to act as a recipient in heterospecific
matings. J. Bacteriol. 171:2238–2240.
28. McEwen, J., and P. Silverman. 1980. Chromosomal mutations of Escherichia
coli that alter expression of conjugative plasmid functions. Proc. Natl. Acad.
Sci. USA 77:513–517.
29. Merriam, J. J., R. Mathur, R. Maxfield-Boumil, and R. R. Isberg. 1997.
Analysis of the Legionella pneumophila fliI gene: intracellular growth of a
defined mutant defective for flagellum biosynthesis. Infect. Immun. 65:2497–
2501.
30. Nagai, H., J. C. Kagan, X. Zhu, R. A. Kahn, and C. R. Roy. 2002. A bacterial
guanine nucleotide exchange factor activates ARF on Legionella phago-
somes. Science 295:679–682.
31. Nakamura, Y., and K. Ito. 1993. Control and function of lysyl-tRNA syn-
thetases: diversity and co-ordination. Mol. Microbiol. 10:225–231.
32. Ninio, S., D. M. Zuckman-Cholon, E. D. Cambronne, and C. R. Roy. 2005.
The Legionella IcmS-IcmW protein complex is important for Dot/Icm-me-
diated protein translocation. Mol. Microbiol. 55:912–926.
33. Ohnishi, H., Y. Mizunoe, A. Takade, Y. Tanaka, H. Miyamoto, M. Harada,
and S. Yoshida. 2004. Legionella dumoffii DjlA, a member of the DnaJ
family, is required for intracellular growth. Infect. Immun. 72:3592–3603.
34. Raivio, T. L. 2005. Envelope stress responses and Gram-negative bacterial
pathogenesis. Mol. Microbiol. 56:1119–1128.
35. Raivio, T. L., and T. J. Silhavy. 1997. Transduction of envelope stress in
Escherichia coli by the Cpx two-component system. J. Bacteriol. 179:7724–
7733.
36. Robinson, C. G., and C. R. Roy. 2006. Attachment and fusion of endoplasmic
reticulum with vacuoles containing Legionella pneumophila. Cell Microbiol.
8:793–805.
37. Ruiz, N., and T. J. Silhavy. 2005. Sensing external stress: watchdogs of the
Escherichia coli cell envelope. Curr. Opin. Microbiol. 8:122–126.
38. Sadosky, A. B., L. A. Wiater, and H. A. Shuman. 1993. Identification of
Legionella pneumophila genes required for growth within and killing of
human macrophages. Infect. Immun. 61:5361–5373.
39. Segal, G., M. Purcell, and H. A. Shuman. 1998. Host cell killing and bacterial
conjugation require overlapping sets of genes within a 22-kb region of the
Legionella pneumophila genome. Proc. Natl. Acad. Sci. USA 95:1669–1674.
40. Segal, G., and H. A. Shuman. 1999. Legionella pneumophila utilizes the same
genes to multiply within Acanthamoeba castellanii and human macrophages.
Infect. Immun. 67:2117–2124.
41. Seshadri, R., I. T. Paulsen, J. A. Eisen, T. D. Read, K. E. Nelson, W. C.
Nelson, N. L. Ward, H. Tettelin, T. M. Davidsen, M. J. Beanan, R. T. Deboy,
S. C. Daugherty, L. M. Brinkac, R. Madupu, R. J. Dodson, H. M. Khouri,
K. H. Lee, H. A. Carty, D. Scanlan, R. A. Heinzen, H. A. Thompson, J. E.
Samuel, C. M. Fraser, and J. F. Heidelberg. 2003. Complete genome se-
quence of the Q-fever pathogen Coxiella burnetii. Proc. Natl. Acad. Sci. USA
100:5455–5460.
42. Sexton, J. A., J. L. Miller, A. Yoneda, T. E. Kehl-Fie, and J. P. Vogel. 2004.
Legionella pneumophila DotU and IcmF are required for stability of the
Dot/Icm complex. Infect. Immun. 72:5983–5992.
43. Sexton, J. A., J. S. Pinkner, R. Roth, J. E. Heuser, S. J. Hultgren, and J. P.
Vogel. 2004. The Legionella pneumophila PilT homologue DotB exhibits
ATPase activity that is critical for intracellular growth. J. Bacteriol. 186:
1658–1666.
44. Sexton, J. A., and J. P. Vogel. 2004. Regulation of hypercompetence in
Legionella pneumophila. J. Bacteriol. 186:3814–3825.
45. Sexton, J. A., and J. P. Vogel. 2002. Type IVB secretion by intracellular
pathogens. Traffic 3:178–185.
46. Sexton, J. A., H. J. Yeo, and J. P. Vogel. 2005. Genetic analysis of the
Legionella pneumophila DotB ATPase reveals a role in type IV secretion
system protein export. Mol. Microbiol. 57:70–84.
47. Swanson, M. S., and R. R. Isberg. 1995. Association of Legionella pneumo-
phila with the macrophage endoplasmic reticulum. Infect. Immun. 63:3609–
3620.
48. Swanson,M. S., and R. R. Isberg. 1996. Identification of Legionella pneumophila
mutants that have aberrant intracellular fates. Infect. Immun. 64:2585–2594.
49. Vogel, J. P., H. L. Andrews, S. K. Wong, and R. R. Isberg. 1998. Conjugative
transfer by the virulence system of Legionella pneumophila. Science 279:873–
876.
50. Wall, D., M. Zylicz, and C. Georgopoulos. 1994. The NH2-terminal 108
amino acids of the Escherichia coli DnaJ protein stimulate the ATPase
activity of DnaK and are sufficient for lambda replication. J. Biol. Chem.
269:5446–5451.




arch 26, 2014 by W
ashington University in St. Louis
http://jb.asm.org/
D
ow
nloaded from
 
